Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Therapy Name | FS120 |
| Synonyms | |
| Therapy Description |
FS120 is a bispecific antibody that targets TNFRSF9 (4-1BB, CD137) and TNFRSF4 (OX40, CD134), which may lead to enhanced anti-tumor immune response (NCI Thesaurus). |
| Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
|---|---|---|---|---|
| FS120 | FS-120|FS 120 | TNFRSF9 Antibody 36 | FS120 is a bispecific antibody that targets TNFRSF9 (4-1BB, CD137) and TNFRSF4 (OX40, CD134), which may lead to enhanced anti-tumor immune response (NCI Thesaurus). |
| Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
|---|
| Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
|---|---|---|---|---|---|---|
| NCT04648202 | Phase I | FS120 | FS120 First in Human Study in Patients With Advanced Malignancies | Active, not recruiting | USA | ESP | 0 |